Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle

被引:490
作者
Daub, Henrik [1 ]
Olsen, Jesper V. [2 ]
Bairlein, Michaela
Gnad, Florian [2 ]
Oppermann, Felix S. [1 ]
Koerner, Roman [3 ]
Greff, Zoltan [5 ]
Keri, Gyoergy [5 ,6 ]
Stemmann, Olaf [4 ]
Mann, Matthias [2 ]
机构
[1] Max Planck Inst Biochem, Dept Mol Biol, Cell Signaling Grp, D-82152 Martinsried, Germany
[2] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany
[3] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany
[4] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany
[5] Vichem Chem Ltd, H-1022 Budapest, Hungary
[6] Semmelweis Univ, Hungarian Acad Sci, Pathobiochem Res Grp, H-1088 Budapest, Hungary
关键词
D O I
10.1016/j.molcel.2008.07.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases are pivotal regulators of cell signaling that modulate each other's functions and activities through site-specific phosphorylation events. These key regulatory modifications have not been studied comprehensively, because low cellular abundance of kinases has resulted in their underrepresentation in previous phosphoproteome studies. Here, we combine kinase-selective affinity purification with quantitative mass spectrometry to analyze the cell-cycle regulation of protein kinases. This proteomics approach enabled us to quantify 219 protein kinases from S and M phase-arrested human cancer cells. We identified more than 1000 phosphorylation sites on protein kinases. Intriguingly, half of all kinase phosphopeptides were upregulated in mitosis. Our data reveal numerous unknown M phase-induced phosphorylation sites on kinases with established mitotic functions. We also find potential phosphorylation networks involving many protein kinases not previously implicated in mitotic progression. These results provide a vastly extended knowledge base for functional studies on kinases and their regulation through site-specific phosphorylation.
引用
收藏
页码:438 / 448
页数:11
相关论文
共 43 条
[1]   Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors [J].
Bantscheff, Marcus ;
Eberhard, Dirk ;
Abraham, Yann ;
Bastuck, Sonja ;
Boesche, Markus ;
Hobson, Scott ;
Mathieson, Toby ;
Perrin, Jessica ;
Raida, Manfred ;
Rau, Christina ;
Reader, Valerie ;
Sweetman, Gavain ;
Bauer, Andreas ;
Bouwmeester, Tewis ;
Hopf, Carsten ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel ;
Rick, Jens ;
Kuster, Bernhard ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2007, 25 (09) :1035-1044
[2]   Large-scale characterization of HeLa cell nuclear phosphoproteins [J].
Beausoleil, SA ;
Jedrychowski, M ;
Schwartz, D ;
Elias, JE ;
Villén, J ;
Li, JX ;
Cohn, MA ;
Cantley, LC ;
Gygi, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (33) :12130-12135
[3]   A probability-based approach for high-throughput protein phosphorylation analysis and site localization [J].
Beausoleil, Sean A. ;
Villen, Judit ;
Gerber, Scott A. ;
Rush, John ;
Gygi, Steven P. .
NATURE BIOTECHNOLOGY, 2006, 24 (10) :1285-1292
[4]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[5]   Reproducible isolation of distinct, overlapping segments of the phosphoproteome [J].
Bodenmiller, Bernd ;
Mueller, Lukas N. ;
Mueller, Markus ;
Domon, Bruno ;
Aebersold, Ruedi .
NATURE METHODS, 2007, 4 (03) :231-237
[6]   Crystal structure and mutational analysis the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1 [J].
Bourne, Y ;
Watson, MH ;
Hickey, MJ ;
Holmes, W ;
Rocque, W ;
Reed, SI ;
Tainer, JA .
CELL, 1996, 84 (06) :863-874
[7]   Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors [J].
Brehmer, D ;
Godl, K ;
Zech, B ;
Wissing, J ;
Daub, H .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (05) :490-500
[8]  
Brehmer D, 2005, CANCER RES, V65, P379
[9]  
Colbach N., 2004, OCL - Oleagineux, Corps Gras, Lipides, V11, P11
[10]   Strategies to overcome resistance to targeted protein kinase inhibitors [J].
Daub, H ;
Specht, K ;
Ullrich, A .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (12) :1001-1010